Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASMIC: Aspirin Effect on Gut Microbiome
NCT02761486Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Aug 2016
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in colorectal cancer (CRC) comparing Aspirin Arm with Placebo Arm (2 arms). Primary endpoint: Composition of the gut microbiome at 12 weeks. Started Aug 2016; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02761486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761486.